HLB파나진 Stock: price and insider trades · South Korea

Every trade that managers of HLB파나진 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 9 insiders have disclosed 24 filings since 18 October 2025.

The record shows 23 purchases on the open market worth €4.8M, made by 9 insiders, against 1 sale worth €3.6M by 1 insider. The amount is not disclosed for 19 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 2 board members and 1 major shareholder among the declarants. The largest single trade was a purchase of €4.7M by Hlb, published on 10 March 2026, equal to 14.0% of the market capitalisation.

In all, 3 purchases were made within 30 days of a purchase by another insider of the company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 29 July 2026, 81 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. Until a filing is published, the market cannot know about the trade.

Compared with its exchange (2,648 companies, median 7 filings), a count of 24 filings is above the norm. The full history, which starts in 2021, counts 42 purchases against 6 sales.

For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from DART (FSS). Past trades are no guide to future returns.